Mariken E. Stegmann

Mariken E. Stegmann

Auto-generated profile, based on publicly available information

Mariken E. Stegmann

Department of Primary and Long-term Care, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2019 in European Journal of Cancer Care
Verified
Journal Article
Open access
PDF file
DBDaan Brandenbarg
Daan Brandenbarg
Saskia MaassSaskia Maass
Saskia Maass
OGOlaf Geerse
Olaf Geerse
MSMariken E. Stegmann
Mariken E. Stegmann
CHCharlotte Handberg
Charlotte Handberg
SDSaskia F. A. Duijts
Saskia F. A. Duijts
Introduction Symptoms of depression, anxiety and distress are common in the first years after a cancer diagnosis, but little is known about the prevalence of these symptoms at the long term. The aim of this review was to describe the prevalence of symptoms of depression, anxiety and distress in long‐term cancer survivors, five or more years after diagnosis, and to provide implications for primary care. Methods We performed a systematic literature search in the PubMed, PsycINFO and CINAHL databases. Studies were eligible when reporting on the prevalence of symptoms of depression, anxiety and/or distress in long‐term cancer survivors (≥5 years after diagnosis), treated with curative intent. Results A total of 20 studies were included. The reported prevalence of depressive symptoms (N = 18) varied from 5.4% to 49.0% (pooled prevalence: 21.0%). For anxiety (N = 7), the prevalence ranged from 3.4% to 43.0% (pooled prevalence: 21.0%). For distress (N = 4), the prevalence ranged from 4.3% to 11.6% (pooled prevalence: 7.0%). Conclusion Prevalences of symptoms of depression, anxiety and distress among long‐term survivors of cancer do not fundamentally differ from the general population. This is reassuring for primary care physicians, as they frequently act as the primary physician for long‐term survivors whose follow‐up schedules in the hospital have been completed.

23 February 2022 in Cancers
Verified
Journal Article
Open access
PDF file
NSNelleke (P.A.L.) Seghers
Nelleke (P.A.L.) Seghers
AWAnke Wiersma
Anke Wiersma
SFSuzanne Festen
Suzanne Festen
MSMariken E. Stegmann
Mariken E. Stegmann
Pierre Louis SoubeyranPierre Louis Soubeyran
Pierre Louis Soubeyran
Marije E. HamakerMarije E. Hamaker
Marije E. Hamaker
For physicians, it is important to know which treatment outcomes are prioritized overall by older patients with cancer, since this will help them to tailor the amount of information and treatment recommendations. Older patients might prioritize other outcomes than younger patients. Our objective is to summarize which outcomes matter most to older patients with cancer. A systematic review was conducted, in which we searched Embase and Medline on 22 December 2020. Studies were eligible if they reported some form of prioritization of outcome categories relative to each other in patients with all types of cancer and if they included at least three outcome categories. Subsequently, for each study, the highest or second-highest outcome category was identified and presented in relation to the number of studies that included that outcome category. An adapted Newcastle–Ottawa Scale was used to assess the risk of bias. In total, 4374 patients were asked for their priorities in 28 studies that were included. Only six of these studies had a population with a median age above 70. Of all the studies, 79% identified quality of life as the highest or second-highest priority, followed by overall survival (67%), progression- and disease-free survival (56%), absence of severe or persistent treatment side effects (54%), and treatment response (50%). Absence of transient short-term side effects was prioritized in 16%. The studies were heterogeneous considering age, cancer type, and treatment settings. Overall, quality of life, overall survival, progression- and disease-free survival, and severe and persistent side effects of treatment are the outcomes that receive the highest priority on a group level when patients with cancer need to make trade-offs in oncologic treatment decisions.

1 October 2019 in Maturitas
Verified
Journal Article
Closed access
MSMariken E. Stegmann
Mariken E. Stegmann
SFSuzanne Festen
Suzanne Festen
DBDaan Brandenbarg
Daan Brandenbarg
JSJan Schuling
Jan Schuling
BLBarbara van Leeuwen
Barbara van Leeuwen
ABAnnette J. Berendsen
Annette J. Berendsen

23 May 2021 in Cancers
Verified
Journal Article
Open access
PDF file
MSMariken E. Stegmann
Mariken E. Stegmann
OGOlaf Geerse
Olaf Geerse
LZLia Van Zuylen
Lia Van Zuylen
LNLarissa Nekhlyudov
Larissa Nekhlyudov
DBDaan Brandenbarg
Daan Brandenbarg
The number of patients that can no longer be cured but may expect to live with their cancer diagnosis for a substantial period is increasing. These patients with ‘prolonged incurable cancer’ are often overlooked in research and clinical practice. Patients encounter problems that are traditionally seen from a palliative or survivorship perspective but this may be insufficient to cover the wide range of physical and psychosocial problems that patients with prolonged incurable cancer may encounter. Elements from both fields should, therefore, be delivered concordantly to further optimize care pathways for these patients. Furthermore, to ensure future high-quality care for this important patient population, enhanced clinical awareness, as well as further research, are urgently needed.

1 September 2021 in Patient Education and Counseling
Verified
Journal Article
Open access
SFSuzanne Festen
Suzanne Festen
MSMariken E. Stegmann
Mariken E. Stegmann
APAnnemiek Prins
Annemiek Prins
Barbara C. van MunsterBarbara C. van Munster
Barbara C. van Munster
BLBarbara L. van Leeuwen
Barbara L. van Leeuwen
DBDaan Brandenbarg
Daan Brandenbarg
For shared decision making, it is crucial to identify patients' priorities regarding health outcomes. Our aim was to study whether healthcare professionals know these priorities. In this cross-sectional study we included older patients who had to make a treatment decision, their general practitioners (GPs) and their medical specialists. Agreement between the patients' main health outcome as prioritised by using the Outcome Prioritization Tool (OPT) and the perception of the same outcome by their healthcare professionals. Eighty-seven patients were included. Median age was 76 years, 87.4% of patients presented with malignant disease. The majority prioritised maintaining independence (51.7%), followed by extending life (27.6%). The agreement between patients and healthcare professionals was low (GPs 41.7%, kappa 0.067, p = 0.39), medical specialists 40.3%, kappa 0.074, p = 0.33). Positively related to agreement was patient's age > 75, and a longer relation with their patients (for GPs), and the patient having no partner (for medical specialist). Having a malignant disease, dependent living and functional deficits were negatively related to agreement. Healthcare professionals have poor perceptions of their patients' priorities. To realise patient-centered care, it is crucial to discuss priorities explicitly with all patients.

22 December 2020 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
MSM. E. Stegmann
M. E. Stegmann
DBD. Brandenbarg
D. Brandenbarg
ARA. K. L. Reyners
A. K. L. Reyners
WGW. H. van Geffen
W. H. van Geffen
THT. J. N. Hiltermann
T. J. N. Hiltermann
ABA. J. Berendsen
A. J. Berendsen
Purpose: To investigate the treatment goals of older patients with non-curable cancer, whether those goals changed over time, and if so, what triggered those changes. Methods: We performed a descriptive and qualitative analysis using the Outcome Prioritization Tool (OPT) to assess patient goals across four conversations with general practitioners (GPs) over 6 months. Text entries from electronic patient records (hospital and general practice) were then analyzed qualitatively for this period. Results: Of the 29 included patients, 10 (34%) rated extending life and 9 (31%) rated maintaining independence as their most important goals. Patients in the last year before death (late phase) prioritized extending life less often (3 patients; 21%) than those in the early phase (7 patients; 47%). Goals changed for 16 patients during follow-up (12 in the late phase). Qualitative analysis revealed three themes that explained the baseline OPT scores (prioritizing a specific goal, rating a goal as unimportant, and treatment choices related to goals). Another three themes related to changes in OPT scores (symptoms, disease course, and life events) and stability of OPT scores (stable situation, disease-unrelated motivation, and stability despite symptoms). Conclusion: Patients most often prioritized extending life as the most important goal. However, priorities differed in the late phase of the disease, leading to changed goals. Triggers for change related to both the disease (e.g., symptoms and course) and to other life events. We therefore recommend that goals should be discussed repeatedly, especially near the end of life. Trial registration: OPTion study: NTR5419